We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Shield Therapeutics Plc | LSE:STX | London | Ordinary Share | GB00BYV81293 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.75 | 1.70 | 1.80 | 1.75 | 1.75 | 1.75 | 633,780 | 08:00:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 4.47M | -40.44M | -0.0522 | -0.34 | 13.57M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/6/2021 08:56 | If you think it is cheap but some more. The price now and any drop is irrelevant unless you are selling or buying. The only thing that matters is future cash flow and that we will not know for a year or two. | purchaseatthetop | |
25/6/2021 08:45 | Crashed it on very low volume !!Pretty sad imo | amaretto1 | |
25/6/2021 08:44 | I mean wtf? Must be a big seller | babbler | |
25/6/2021 08:43 | This is seriously poor .. on any measure | amaretto1 | |
25/6/2021 07:35 | Sorry frinvest....I had not spotted that! Nice that we both considered it but maybe I read yours and that triggered it later. Now we sit back and wait with our feet up. Nothing to really think about until we get a progress update. Been fun. Going to get a lot more fun. Luckily I am already considerably in the blue and that is a comfortable place to be thinking three years from now. Five bagged by then? Most likely. Just my view. | purchaseatthetop | |
25/6/2021 07:14 | purchaseatthetop - I've already made your point in post 2586 and makes sense especially as Covid-19 is here to stay for a long time to come. | frrinvest | |
25/6/2021 04:28 | Early morning here in lovely Italy. A thought struck me last night that I have been mulling over. Covid19 might make upselling Accrufer a lot easier. The last place that vulnerable people will want to go for the next few years is a hospital, clinic or even a home IV visit. Much safer to take oral medicine. Does that make sense? | purchaseatthetop | |
24/6/2021 21:20 | Anyone able to share the ANLC update announced at 19.56? To see what lifted full year predictions looks like thanks | luisfrg | |
24/6/2021 20:15 | After hours trade 150,000 @ 57p £85500 showing as a buy. | oapknob1 | |
24/6/2021 18:45 | Cyberbub...exactly. Put yourself in the (unfortunate) position of a 62 year old who has iron deficiency in Dallas Texas. Given the choice of taking a pill or going to the hospital for IV...which ones would you do? Wait till August or September. Enjoy the summer. STX is finally after all these years selling. What's not to like? | purchaseatthetop | |
24/6/2021 18:38 | The stock market *always* sells on good news, especially if expected. No probs - there will be further progress announcements in coming weeks, and first revenues soon! | cyberbub | |
24/6/2021 17:40 | Toffeeman.....nature of the market. I was astounded that the price did not rise in the logical way I looked at it as I had calculate free cash flows, variance analysis on their sales levels and worked out it was money for nothing (get your chicks for free). I was not surprised because the market is irrational and behaves in ways that my slightly aspergers mind does not. It seems that most investors do not like reading detailed reports and are happy to make a profit and move on. So....you can be astounded but knowing that people do not think like you, not be surprised. Just like ENET today. Down 12%. Is that bad...no it is great. It is massively undervalued because it is so complex and investors want their profits now or they stamp their feet. I now buy ENET. Anyway...end of my little explanation. There is no logic short term in the market and never try to find it. I look at free cash flow two to five years in the future. What happens on the way is for the birds. STX. ITX. AGL. ENET. BMN. All five are the future* *subject to Known unknowns and if it goes wrong blame ohojim. | purchaseatthetop | |
24/6/2021 17:15 | It means news leaked or known prior as it's in price by the time it's announced | 78steve | |
24/6/2021 16:46 | Seems to be the trend all round now, a good RN and the share price drops. | machinist | |
24/6/2021 16:42 | >> PATT how is it possible to be astounded and not surprised? | toffeeman | |
24/6/2021 16:36 | No worries. GLA | 78steve | |
24/6/2021 16:30 | 78steve....I hold my hands out in apology. You were right possibly. I am astounded but not surprised. I will just buy more if they are giving them away. | purchaseatthetop | |
24/6/2021 16:15 | I gave up trying! Bad start | powerp2 | |
24/6/2021 16:07 | My slight red prediction on the day isn't far off! When i made this prediction in morning today Purchaseathetop implied i was taking drugs i.e. not in fit mental state. Wonder what he has to say now! | 78steve | |
24/6/2021 15:56 | we ain't going anywhere until the placing investors aren't done cashing in that much has become clear this last week or so.. regardless of the prospects and potential we'd probably be more highly valued if they de-listed here and went full on stateside.. | kalkaar | |
24/6/2021 15:55 | I'm not in this for immediate returns but price action is unquestionably disappointing | reviewwworld | |
24/6/2021 15:39 | exec summary: - mighty impressive CEO - very confident and "sounded business savvy" - no waffle or BS - He knows what they've got and seems genuinely excited by the opportunity - he knows the market place - he knows who the target market is (patients perspective) - he know the prescription writers are the focus - got the initial sales force on the case - looking to add to the sales team early 2022 - all supplies in the system ready for shipping all in all pretty darn good albeit a little rushed real risk, imho, is STX getting taken out at low valuation now everything is in place.. wouldn't be surprised if this was a yank takeover given the market and team running the show.. purely hypothetical but would be interesting to know how many would take 100-125p today vs. holding on for a bigger payday say 2 years down the line.. food for thought | kalkaar | |
24/6/2021 15:38 | PATT - previously STX has stated accrufer will be priced similar to IV but without all the add on costs. However, clearly it is not that simple as the number of IV a person needs will depend on their iron levels and how quickly it is absorbed - the average is about 3 sessions. The other thing with IV is that top ups may be needed e.g. every 3 months. Again this will vary per person. Below is a quick link to an iron clinic - they charge £570 per session so 3 sessions would be £1,700. About $2,500. 4 months of Accrufer is $2k and 6 months is $3k. So there is your comparison. I think the USP for Accrufer is it's simplicity. No pre tests , no hospital visits, no monitoring etc. BTW i'm not having a pop but your 1 month comparison is just wrong. When H2H studies were undertaken with IV Accrufer was c75% as effective after 12 weeks but comparable after 24 weeks (this was an unfair study for STX as patients could have as many IV top ups as required, so to get that close after 12 weeks is still a positive). STX estimate a 4 month treatment per patient. hxxps://www.theironc | shandypants2 | |
24/6/2021 15:35 | Yep, disappointing that there was no Q&A and I believe quite a few problems for some investors logging in, the link below should take you to the presentation,… Edit - apologies the link does not work. | swizz | |
24/6/2021 15:34 | Potential launch in China in 2023. 11.4 million dollar milestone on approval Royalties 10-15%, sales milestones up to 40 million | nobbygnome |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions